InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Sep 27, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Sep 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure, details to follow.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on September 27, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, dollar amounts, or specific dates beyond the filing date itself.
Why It Matters
This filing indicates InfuSystem Holdings is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial or operational impact indicated.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- September 27, 2024 (date) — Filing Date
- Regulation FD (regulation) — Disclosure Type
FAQ
What specific information is being disclosed under Regulation FD?
The provided text of the 8-K filing does not specify the exact nature of the Regulation FD disclosure.
When was the earliest event reported in this filing?
The earliest event reported is dated September 27, 2024.
What is the principal executive office address of InfuSystem Holdings, Inc.?
The principal executive office is located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What is the Commission File Number for InfuSystem Holdings, Inc.?
The Commission File Number is 001-35020.
What is the Standard Industrial Classification code for InfuSystem Holdings, Inc.?
The SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 546 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-09-27 06:30:27
Filing Documents
- infu-20240927.htm (8-K) — 28KB
- exhibit99109-27x2024lytham.htm (EX-99.1) — 14KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-24-041426.txt ( ) — 1204KB
- infu-20240927.xsd (EX-101.SCH) — 2KB
- infu-20240927_lab.xml (EX-101.LAB) — 21KB
- infu-20240927_pre.xml (EX-101.PRE) — 12KB
- infu-20240927_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure On September 27, 2024 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that Richard DiIorio, Chief Executive Officer, Carrie Lachance, President and Chief Operating Officer and Barry Steele, Chief Financial Officer will participate in Lytham Partners Fall 2024 Conference on Tuesday, October 1, 2024. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated September 27 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: September 27, 2024